About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72721 record(s)
Req # A-2019-001611
Adverse Reaction Report (AER). Report number: 000726028.Organization: Health Canada
February 2020
Req # A-2019-001745
Adverse Reaction Report (AER). Report number: E2B_02568767.Organization: Health Canada
February 2020
Req # A-2019-001613
Adverse Reaction Report (AER) for AXIME SODIUM. Report number: E2B_02224261.Organization: Health Canada
February 2020
Req # A-2019-001614
Adverse Reaction Report (AER). Report numbers: E2B_02593011, E2B_02644417, E2B_02642113, E2B_02689159, 000727261, E2B_02452806 E2B_02475526, E2B_02483255, E2B_02758145, E2B_01831646, E2B_01277579.Organization: Health Canada
February 2020
Req # A-2019-001615
Adverse Reaction Report (AER) for CODEINE PHOSPHATE, DOXYLAMINE SUCCINATE, PARACETAMOL. Report number: 000721617.Organization: Health Canada
February 2020
Req # A-2019-001636
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-118055-822, Drug-Checking Technology Challenge.Organization: Health Canada
February 2020
Req # A-2019-001639
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-111348-597, Current Status of the Pain Task Force on the current status of the Pain Task Force, the external advisory panel and the next steps.Organization: Health Canada
February 2020
Req # A-2019-001643
Adverse Reaction Report (AER) for FUROSEMIDE. Report number: E2B_02643402.Organization: Health Canada
February 2020
Req # A-2019-001672
Adverse Reaction Report (AER). Report number: E2B_02532309.Organization: Health Canada
February 2020
Req # A-2019-001673
Adverse Reaction Report (AER). Report number: E2B_02639171.Organization: Health Canada
February 2020